Alternatives to Eden

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

• $47/mo cheaper than Eden
• has an oral option if you would rather not inject

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

One flat $195/mo price for compounded GLP-1 therapy, injection or sublingual, regardless of which molecule — plus a brand-name lane (Ozempic, Wegovy, Mounjaro) for mothers who want an on-label pen instead. Its full pricing only renders inside the signup flow, and the state list isn't published.

• $1/mo cheaper than Eden
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

• $21/mo cheaper than Eden

This is a real surgical practice rather than a telehealth brand — a Hollywood, Florida bariatric center with a named surgeon, doing gastric sleeves and bypasses alongside the injections. Semaglutide runs $69 a week or $179 a month; tirzepatide starts at $279. Two things need care. Its package labels overstate their own length — "2.5-Month (10 Weeks)" is 2.3 months and "5-Month (20 Weeks)" is 4.6 — and the practice markets retatrutide, a drug that is not approved anywhere for anything.

• $17/mo cheaper than Eden
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear, and there's no postpartum or PCOS-specific content.

• $17/mo cheaper than Eden
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Four named pharmacies, a named prescribing partner and brand-name Wegovy, Zepbound and Ozempic alongside the compounded line — that is a fuller disclosure than most of this roster manages. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249, and the price attaches to the form rather than the molecule: the product page never says whether you are getting semaglutide or tirzepatide, and the terms confirm both are in scope. Two things deserve a mother's attention before she enrolls. The brand products are priced as a membership plus an undisclosed medication cost, and that membership is quoted at two different figures on one page, $99 beside Zepbound and Wegovy and $171 beside Ozempic. And the terms state that if a provider decides a different molecule suits you better, staying enrolled is itself your consent to the switch and the charges continue. It also discloses, unusually plainly, that people shown in its advertising may be actors or artificial intelligence rather than clinicians.

• $17/mo cheaper than Eden
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• has an oral option if you would rather not inject